Financhill
Back

Theriva Biologics Quote, Financials, Valuation and Earnings

Theriva Biologics Price Quote

$1.29
+0.01 (+0.78%)
(Updated: November 23, 2024 at 3:17 AM ET)

Theriva Biologics Key Stats

Sell
44
Theriva Biologics (TOVX) is a Sell

Day range:
$1.27 - $1.32
52-week range:
$1.22 - $17.11
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.14%

Volume:
49.2K
Avg. volume:
3.2M
1-year change:
-89.76%
Market cap:
$3.6M
Revenue:
$0
EPS:
$-33.18

How Much Does Theriva Biologics Make?

Data Unavailable

Is Theriva Biologics Growing As A Company?

Data Unavailable

Theriva Biologics Stock Price Performance

  • Did Theriva Biologics Stock Go Up Last Month?
    Theriva Biologics share price went down by -11.72% last month
  • Did TOVX's Share Price Rise Over The Last Year?
    TOVX share price fell by -89.76% over the past 1 year

What Is Theriva Biologics 52-Week High & Low?

Theriva Biologics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Theriva Biologics?

  • How Much Debt Does Theriva Biologics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Theriva Biologics Have?
    Cash and short term investments quarterly total is $16.4M
  • What Is Theriva Biologics’s Book Value Per Share?
    Book value per share is 9.41

Is Theriva Biologics Cash Flow Positive?

  • What Is TOVX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$18.8M
  • What Is Theriva Biologics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $4M
  • What Is Theriva Biologics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$57K

Theriva Biologics Return On Invested Capital

Data Unavailable

Theriva Biologics Earnings Date & Stock Price

Theriva Biologics Competitors

  • Who Are Theriva Biologics's Competitors?
    Below is a list of companies who compete with Theriva Biologics or are related in some way:
    • BioCardia Inc (BCDA)
    • Merck & Co Inc (MRK)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Pro-Dex Inc (PDEX)
    • Palatin Technologies Inc (PTN)

Theriva Biologics Dividend Yield

Theriva Biologics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -29.71%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 90.50
Upside from Last Price: 6970.31%

Major Shareholders

  • How many TOVX shares are owned by institutional investors?
    1.6M TOVX shares are owned by institutional investors
  • How many TOVX shares are owned by insiders?
    6.6M TOVX shares are owned by insiders